Jiangsu Aidea Pharmaceutical. is a Distributor/Import Export, Manufacturer/Innovator, Generics/Biosimilars Manufacturer company operating in the pharmaceutical industry.
Jiangsu Aidea Pharmaceutical Co., Ltd. ( Aidea Pharma , 688488.SH) was established in 2009 and listed on the Shanghai Stock Exchange STAR Market in 2020. As a high-tech pharmaceutical company, Aidea Pharma focuses on the development of anti-HIV/AIDS product portfolio while leveraging its competitive advantages in the field of human urinary proteins production, natural herbal medicines and probiotics medicines. – A pioneer in R&D of anti-HIV/AIDS products in China, with two innovative drugs successfully approved for marketing – A leading manufacturer of human urinary protein products in China, with five products recognized as provincial high-tech products – A company dedicated to exploring innovative medicines, serving unmet clinical needs worldwide with its unique expertise and professional talents
Company type
Distributor/Import Export, Manufacturer/Innovator, Generics/Biosimilars Manufacturer
Products and services
Pharmaceutical Products / ATC coding, Intermediates, Fine and Specialty Chemicals, Finished Dosage Forms, APIs (Active Pharmaceutical Ingredients)
Markets
Africa, East Asia (e.g. China, Japan, Korea), Europe – EU countries, South America (e.g. Brazil, Colombia), South Asia (e.g. India, Pakistan, Sri Lanka), South East Asia (e.g. Thailand, Philippines, Singapore)
Useful Links
Connect with Jiangsu Aidea Pharmaceutical. on LinkedIn
Address
Jiangsu Aidea Pharmaceutical., No. 69, Xin Ganquan West Road, Hanjiang District, Yangzhou, China, 225008
